¿¬¼ö°­ÁÂ
´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18

´ëÇѾȽŰæÀÇÇÐȸ Neurology of eye movements : 2024-05-18
±³À°ÀÏÀÚ : 2024-05-18
±³À°Àå¼Ò : ¼­¿ï ¼­¿ï´ëº´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) 1F ¼­¼ºÈ¯¿¬±¸È¦

±³À°ÁÖÁ¦ : Neurology of eye movements

ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾȽŰæÀÇÇÐȸ

´ã´çÀÚ : ±èÀ¯Áø
¿¬¶ôó : 02-974-8606

À̸ÞÀÏ : ksno2012@gmail.com

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 40,000¿ø  

ºñ°í »çÀüµî·Ïºñ: Àü¹®ÀÇ 30,000, ´çÀϵî·Ïºñ: Àü¹®ÀÇ 40,000 / Àü°øÀÇ ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 09:05~09:25 Transient monocular & binocular blindness ÀÌÁÖ¿µ(°¡Å縯ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 09:25~09:45 Ptosis (myogenic, N-M junction, neurogenic) ±ÇÀºÁø(Ãæ³²ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 09:45~10:05 Paralytic vs non-paralytic strabismus À±¼Ò¿¬(¿¬¼¼ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:05~10:25 Anisocoria  °­ÁøÁÖ(ÀüºÏÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:25~10:35 Q & A -(-)

ÈÞ½Ä 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:35~10:50 ÈÞ½Ä -(-)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 10:50~11:15 Understanding of eye movement and objective measurement ÀÓÇÑ¿õ(ÇѾçÀÇ´ë ¾È°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 11:15~11:40 Eye movement recording using virtual reality and deep-learning model È«¼º±¤(ÇѸ²ÀÇ´ë À̺ñÀÎÈÄ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 11:40~12:00 Saccadic analysis: update  ÃÖ¼­¿µ(ºÎ»êÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 12:00~12:10 Q & A -(-)

½Ä»ç 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 12:10~13:10 ÃÑȸ ¹× Lunch -(-)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 13:10~13:35 Afferent visual symptoms and traumatic optic neuropathy  ½ÅÇöÁø(°Ç±¹ÀÇ´ë ¾È°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 13:35~13:55 Efferent visual symptoms and eye movement abnormalities    ÀÌÀͼº(¼øõÇâÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 13:55~14:15 Post-traumatic dizziness Á¤ÀϾï(°Ç±¹ÀÇ´ë ½Å°æ°ú)

Åä·Ð 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:15~14:25 Q & A -(-)

ÈÞ½Ä 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:25~14:40 ÈÞ½Ä -(-)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:40~14:55 (±¸¿¬¹ßÇ¥)ANCA-associated pachymeningitis and bilateral optic neuropathy treated with steroid pulse therapy        ±èÈ«³²(¾ÆÁÖÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 14:55~15:10 (±¸¿¬¹ßÇ¥)Clinical Characteristics and Genetic Analysis of Chronic Progressive External Ophthalmoplegia À̼÷¹Î(ºÎ»êÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 15:10~15:25 (±¸¿¬¹ßÇ¥)Neuro-ophthalmologic and neuro-otologic findings in spinocerebellar ataxia type 7 ±èÀç¸í(Àü³²ÀÇ´ë ½Å°æ°ú)

±³À°½Ã°£ 05¿ù 18ÀÏ ¼­¼ºÈ¯¿¬±¸È¦ 15:25~15:40 (±¸¿¬¹ßÇ¥)Hypertensive optic neuropathy    ¹ÚÁöÀ±(¿ï»êÀÇ´ë ½Å°æ°ú)

 

  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[´ë±¸] Á¦27Â÷ ´ëÇѽÉÀåÇÐȸ ´ë±¸°æºÏÁöȸ ÀÓ»ó½ÉÀåÇÐ ¿¬¼ö°­Á : 2024-03-24

±³À°ÀÏÀÚ : 2024-03-24 ±³À°Àå¼Ò : ´ë±¸ ÀÎÅÍºÒ°í ¸¸Ã̵¿ ÄÁº¥¼ÇȦ 2Ãþ ±³À°ÁÖÁ¦ : Á¦27Â÷ ´ëÇѽÉÀåÇÐȸ ´ë±¸°æºÏÁöȸ ÀÓ»ó½ÉÀåÇÐ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ ½ÃÇà±â

Ãßõ¼ö : 0 , Á¶È¸¼ö : 8,349 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ Áú°ü¸® ½ÉÆ÷Áö¿ò : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ BPEX 5Ãþ ÄÁÆÛ·±½ºÈ¦ ±³À°ÁÖÁ¦ : 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ Áú°ü¸® ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ´ëÇÑ

Ãßõ¼ö : 0 , Á¶È¸¼ö : 8,290 , ´ñ±Û¼ö : 0

[ºÎ»ê] 2024³â ´ëÇѽÉÀåÇÐȸ ºÎ¿ï°æÁöȸ Ãá°è¿¬¼ö°­Á : 2024-03-23

±³À°ÀÏÀÚ : 2024-03-23 ±³À°Àå¼Ò : ºÎ»ê º¤½ºÄÚ Á¦1Àü½ÃÀå 311È£ ±³À°ÁÖÁ¦ : 2024³â ´ëÇѽÉÀåÇÐȸ ºÎ¿ï°æÁöȸ Ãá°è¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú

Ãßõ¼ö : 0 , Á¶È¸¼ö : 8,104 , ´ñ±Û¼ö : 0

[¼­¿ï] ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ¿¬¼ö°­Á (ÀüÁ¾°ü ±³¼ö´Ô ¸í¿¹ÅðÀÓ ±â³ä) : 2024-02-25

±³À°ÀÏÀÚ : 2024-02-25 ±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø º»°ü ÁöÇÏ 1Ãþ ±èÁ¾±â Ȧ ±³À°ÁÖÁ¦ : ¼­¿ï´ëÇб³º´¿ø »êºÎÀΰú ¿¬¼ö°­Á (ÀüÁ¾°ü ±³¼ö´Ô ¸í¿¹ÅðÀÓ ±â³ä)ÁÖÃÖ±â°ü : ¼­

Ãßõ¼ö : 0 , Á¶È¸¼ö : 8,409 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-2..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ±³À°ÁÖÁ¦ : Treatment and management of symptoms and physical health i

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,916 , ´ñ±Û¼ö : 0